Evidence map›Paper›PMID 37716996›Full record

ArticleBMC chemistry2023

Characterization of green synthesized selenium nanoparticles (SeNPs) in two different indigenous halophilic bacteria.

Maryam Tabibi, Soheil Aghaei, Mohammad Ali Amoozegar, Razieh Nazari, Mohammad Reza Zolfaghari

Open access · goldAbstract read
In one paragraph

Article in BMC chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Nanomaterials (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Maryam TabibiDepartment of Microbiology, Qom Branch, Islamic Azad University, Qom, 3749113191, Iran.
Soheil AghaeiDepartment of Microbiology, Qom Branch, Islamic Azad University, Qom, 3749113191, Iran. soheilaghaee@yahoo.com.
Mohammad Ali AmoozegarExtremophiles Lab., Dept. of Microbiology, School of Biology, College of Science, University of Tehran, Tehran, Iran. amoozegar@ut.ac.ir.
Razieh NazariDepartment of Microbiology, Qom Branch, Islamic Azad University, Qom, 3749113191, Iran.
Mohammad Reza ZolfaghariDepartment of Microbiology, Faculty of Basic Science, Qom Branch, Islamic Azad University, Qom, Iran.
Qom Islamic Azad University · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the biological method, using nonpathogenic and extremophile bacteria systems are not only safe and highly efficient but also a trump card for synthesizing nanoparticles. Halomonas elongata QW6 IBRC-M 10,214 (He10214) and Salinicoccus iranensis IBRC-M 10,198 (Si10198), indigenous halophilic bacteria, can be used for synthesizing selenium nanoparticles (SeNPs).

methodsSeNP biosynthesis was optimized in two halophilic bacteria and characterized by UV-Vis, Fourier transform infrared spectroscopy (FTIR), transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), X-ray powder diffraction (XRD), zeta potential, and energy dispersive X-ray (EDX).

resultsOptimized conditions for synthesizing SeNPs was at 300 °C at 150 rpm for 72 h and 6 mM or 8 mM concentration of Na

conclusionsHalophilic bacteria, owing to easy manipulation to create optimization conditions and high resistance, could serve as appropriate organisms for the bioproduction of nanoparticles. The biological method, due to effectiveness, flexibility, biocompatibility, and low cost, could be used for the synthesis of reproducible and stable nanoparticles.

Indexed as

BiosynthesisGreen synthesisIranSelenium nanoparticles (SeNPs)

Identifiers

PMID37716996
PMCPMC10504756
OpenAlexW4386803500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.